A formula 1, wherein A1, A2, A3, A4, a7, A8, A9 and A10 are n, the rest are C； A5 is NR5, or s； R1 and R10 are h, cyanogen, halogen, and isocyclic 4-10 substitute or non substitute members respectively； R2 is h, C1-C8 tar, alquenilo c2-c8, cyanogen, halogen, etc.； R3 is h, Whether C1-C8 tar is replaced by 1 or more halides, 1 or more Oh, arilo C6-C10, cyanogen, etc.； R4 is h, C1-C8 tar, cycloquilo c3-c8, cyanogen, hydrogen poisoning, hydroxyl, etc.； R5 is h, C1-C8 tar, C1-C8 tar, C1-C8 tar, c2-c8 tar, etc.； R6 and R6 'are C1-C8, C8 and C8. Or form c3-c8 bike togetherHterocyclolaquilo, other of 4-10 members replaced or not replaced； R7 is h, halogeno, aloxyl C1-C8, aculfonilo C1-C8, nitro, etc.； R8 is h, C1-C8 replaced or not replaced C1-C8 tar, alquenilo c2-c8, cyclopentyl c3-c8, alcoxiilo C1-C8, oxo, Ciano, asphalt, etc.； R9 is h, asphalt C1-C8, Nile C8, C8, halogen-c8, etc There are others The preferred compound is 9 - (4-isopropyl-piperazin-1-il) - 6, 6-dimethyl-11-oxo-6, 11-dihydro-5h-benzo [b] carbazol-3-carbon. These compounds are ALC butyl inhibitors for cancer, metabolism and depression.REFERIDA A UN COMPUESTO DE FORMULA I, DONDE UNO DE A1, A2, A3, A4, A7, A8, A9 Y A10 ES N Y LOS RESTANTES C； A5 ES NR5, O, S； R1 Y R10 SON CADA UNO H, CIANO, HALOGENO, HETEROCICLOALQUILO DE 4-10 MIEMBROS SUSTITUIDO O NO； R2 ES H, ALQUILO C1-C8, ALQUENILO C2-C8, CIANO, HALOGENO, ENTRE OTROS； R3 ES H, ALQUILO C1-C8 SUSTITUIDO O NO CON 1 O MAS HALOGENOS, 1 O MAS OH, ARILO C6-C10, CIANO, ENTRE OTROS； R4 ES H, ALQUILO C1-C8, CICLOALQUILO C3-C8, CIANO, HIDROXICARBONILO, HIDROXILO, ENTRE OTROS； R5 ES H, ALQUILO C1-C8, ALQUILSULFONILO C1-C8, ALQUINILO C2-C8, ENTRE OTROS； R6 Y R6' SON CADA UNO ALQUILO C1-C8, ALQUENILO C2-C8, O JUNTOS FORMAN CICLOALQUILO C3-C8, HTEROCICLOALQUILO DE 4-10 MIEMBROS SUSTITUIDO O NO, ENTE OTROS； R7 ES H, HALOGENO, ALCOXILO C1-C8, ALQUILSULFONILO C1-C8, NITRO, ENTRE OTROS； R8 ES H, ALQUILO C1-C8 SUSTITUIDO O NO, ALQUENILO C2-C8, CICLOALQUILO C3-C8, ALCOXICARB
